Database‐aided ultrahigh‐performance liquid chromatography Q‐Exactive‐Orbitrap tandem mass spectrometry putatively identifies 16 unexpected compounds and three anticounterfeiting pharmacopoeia quality markers for Perillae Fructus
Rapid Communications in Mass Spectrometry · 15.07.2024 · 38 (13)
DOI: 10.1002/rcm.9762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2024-05. Verfasst von Ban Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Fermentation Engineering (Ministry of Education), Cooperative Innovation Centre of Industrial Fermentation (Ministry of Education &…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Drugs, Chinese Herbal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Doctoral Research Initiation Grant of Hubei University of Technology.
Abstract (Originalsprache)
Rationale
Perillae Fructus (PF) is a common traditional Chinese medicine (TCM) for the treatment of asthma. It has not been effectively characterized by rosmarinic acid (RosA), which is currently designed as the sole quality indicator in the Chinese Pharmacopoeia.
Methods
This study introduced a database‐aided ultrahigh‐performance liquid chromatography equipped with quadrupole‐Exactive‐Orbitrap mass spectrometry (UHPLC/Q‐Exactive‐Orbitrap MS/MS) technology to putatively identify the compounds in PF, followed by literature research, quantum chemical calculation, and molecular docking to screen potential quality markers (Q‐markers) of PF.
Results
A total of 27 compounds were putatively identified, 16 of which had not been previously found from PF. In particular, matrine, scopolamine, and RosA showed relatively high levels of content, stability, and drug‐likeness. They exhibited interactions with the asthma‐related target and demonstrated the TCM properties of PF.
Conclusions
The database‐aided UHPLC/Q‐Exactive‐Orbitrap MS/MS can identify at least 27 compounds in PF. Of these, 16 compounds are unexpected, and three compounds (matrine, scopolamine, and RosA) should be considered anticounterfeiting pharmacopoeia Q‐markers of PF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Fermentation Engineering (Ministry of Education), Cooperative Innovation Centre of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei University of Technology, Wuhan, China.
- School of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
ORCID-Profile: Ban Chen
Förderung
- National Natural Science Foundation of China
- Doctoral Research Initiation Grant of Hubei University of Technology
Zitieren
APA
Chen, B., Liu, S., Li, X., Cai, R., Li, C., Hu, Y., Su, J., & Lei, T. (2024). Database‐aided ultrahigh‐performance liquid chromatography Q‐Exactive‐Orbitrap tandem mass spectrometry putatively identifies 16 unexpected compounds and three anticounterfeiting pharmacopoeia quality markers for Perillae Fructus. Rapid Communications in Mass Spectrometry, 38(13). https://doi.org/10.1002/rcm.9762
Vancouver
Chen B, Liu S, Li X, Cai R, Li C, Hu Y, et al. Database‐aided ultrahigh‐performance liquid chromatography Q‐Exactive‐Orbitrap tandem mass spectrometry putatively identifies 16 unexpected compounds and three anticounterfeiting pharmacopoeia quality markers for Perillae Fructus. Rapid Communications in Mass Spectrometry. 2024;38(13). doi:10.1002/rcm.9762
BibTeX
@article{Chen2024,
author = {Chen, Ban and Liu, Shuangshuang and Li, Xican and Cai, Rongxin and Li, Chunhou and Hu, Yuchen and Su, Jiangtao and Lei, Tongxun},
title = {Database‐aided ultrahigh‐performance liquid chromatography Q‐Exactive‐Orbitrap tandem mass spectrometry putatively identifies 16 unexpected compounds and three anticounterfeiting pharmacopoeia quality markers for Perillae Fructus},
journal = {Rapid Communications in Mass Spectrometry},
year = {2024},
volume = {38},
number = {13},
doi = {10.1002/rcm.9762}
}
EUVIMED